Combined treatment modality for anaplastic oligodendroglioma and oligoastrocytoma: A 10-year update of a phase II studyJEREMIC, Branislav; MILICIC, Biljana; GRUJICIC, Danica et al.International journal of radiation oncology, biology, physics. 2004, Vol 59, Num 2, pp 509-514, issn 0360-3016, 6 p.Article

Comparative genetic analysis of metachronous anaplastic oligoastrocytomas with extended recurrence-free intervalMARTINEZ, Ramon; SCHACKERT, Hans-Konrad; KIRSCH, Matthias et al.Journal of neuro-oncology. 2005, Vol 72, Num 2, pp 95-102, issn 0167-594X, 8 p.Article

Concurrent CIC mutations, IDH mutations, and 1 p/19q loss distinguish oligodendrogliomas from other cancersYIP, Stephen; BUTTERFIELD, Yaron S; CORBETT, Richard et al.Journal of pathology (Print). 2012, Vol 226, Num 1, pp 7-16, issn 0022-3417, 10 p.Article

Intra-Arterial Chemotherapy With Osmotic Blood-Brain Barrier Disruption for Aggressive Oligodendroglial Tumors: Results of a Phase I Study. CommentaryGUILLAUME, Daniel J; DOOLITTLE, Nancy D; GAHRAMANOV, Seymur et al.Neurosurgery. 2010, Vol 66, Num 1, pp 48-58, issn 0148-396X, 11 p.Article

Repeated Molecular Testing in Gliomas: A Retrospective Study of 53 CasesMAHAJAN, Dipti; PRAYSON, Richard A.American journal of clinical pathology. 2009, Vol 132, Num 1, pp 118-124, issn 0002-9173, 7 p.Article

Relationship between ornithine decarboxylase levels in anaplastic gliomas and progression-free survival in patients treated with DFMO-PCV chemotherapyLEVIN, Victor A; JOCHEC, Jacob L; SHANTZ, Lisa M et al.International journal of cancer. 2007, Vol 121, Num 10, pp 2279-2283, issn 0020-7136, 5 p.Article

Functional endothelin ET_B receptors are selectively expressed in human oligodendrogliomasANGUELOVA, E; BEUVON, F; LEONARD, N et al.Molecular brain research. 2005, Vol 137, Num 1-2, pp 77-88, issn 0169-328X, 12 p.Article

New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951GORLIA, Thierry; DELATTRE, Jean-Yves; VAN DEN BENT, Martin J et al.European journal of cancer (1990). 2013, Vol 49, Num 16, pp 3477-3485, issn 0959-8049, 9 p.Article

GFAP-Positive Neoplastic Astrocytes in Spontaneous Oligodendrogliomas and Mixed Gliomas of RatsNAGATANI, Mariko; YAMAKAWA, Seiki; SAITO, Tsubasa et al.Toxicologic pathology. 2013, Vol 41, Num 4, pp 653-661, issn 0192-6233, 9 p.Article

Age at diagnosis and loss of heterozygosity on chromosome 1p and 19q in oligodendroglial tumorsHERGERSBERG, M; MARIANI, L; VASSELLA, E et al.Journal of neuro-oncology. 2006, Vol 80, Num 2, pp 215-217, issn 0167-594X, 3 p.Article

Reclassification of oligoastrocytomas by loss of heterozygosity studiesEOLI, Marica; BISSOLA, Lorena; BOIARDI, Amerigo et al.International journal of cancer. 2006, Vol 119, Num 1, pp 84-90, issn 0020-7136, 7 p.Article

Molecular genetic analysis of oligodendroglial tumorsHARTMANN, Christian; MUELLER, Wolf; LASS, Ulrike et al.Journal of neuropathology and experimental neurology. 2005, Vol 64, Num 1, pp 10-14, issn 0022-3069, 5 p.Article

Efficacy of Gamma Knife Radiosurgery for Small-Volume Recurrent Malignant Gliomas After Initial Radical ResectionELLIOTT, Robert E; PARKER, Erik C; RUSH, Stephen C et al.World neurosurgery (Print). 2011, Vol 76, Num 1-2, pp 128-140, issn 1878-8750, 13 p.Article

The Ki-67 labeling index as a prognostic factor in Grade II oligoastrocytomasSHAFFREY, Mark E; FARACE, Elana; SCHIFF, David et al.Journal of neurosurgery. 2005, Vol 102, Num 6, pp 1033-1039, issn 0022-3085, 7 p.Article

Molecular pathogenesis of oligodendroglial tumorsJEUKEN, Judith W. M; VON DEIMLING, Andreas; WESSELING, Pieter et al.Journal of neuro-oncology. 2004, Vol 70, Num 2, pp 161-181, issn 0167-594X, 21 p.Article

Recurrent low-grade gliomas: the role of fractionated stereotactic re-irradiationCOMBS, S. E; AHMADI, R; SCHULZ-ERTNER, D et al.Journal of neuro-oncology. 2005, Vol 71, Num 3, pp 319-323, issn 0167-594X, 5 p.Article

Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972VAN DEN BENT, M. J; CHINOT, O; BOOGERD, W et al.Annals of oncology. 2003, Vol 14, Num 4, pp 599-602, issn 0923-7534, 4 p.Article

Identification of two contiguous minimally deleted regions on chromosome 1 p36.3 1-p36.32 in oligodendroglial tumoursDONG, Z; PANG, Jc-S; NG, M. H et al.British journal of cancer. 2004, Vol 91, Num 6, pp 1105-1111, issn 0007-0920, 7 p.Article

Association between chromosome 1p and 19q loss and outcome in pediatric malignant gliomas: Results from the CCG-945 cohortPOLLACK, Ian F; FINKELSTEIN, Sydney D; BURNHAM, Judith et al.Pediatric neurosurgery. 2003, Vol 39, Num 3, pp 114-121, issn 1016-2291, 8 p.Article

Chromosomal anomalies in oligodendroglial tumors are correlated with clinical featuresVAN DEN BENT, Martin J; LOOIJENGA, Leendert H. J; LANGENBERG, K et al.Cancer. 2003, Vol 97, Num 5, pp 1276-1284, issn 0008-543X, 9 p.Conference Paper

Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristineBIEMOND-TER STEGE, Elize M; KROS, Johan M; DE BRUIN, Hein G et al.Cancer. 2005, Vol 103, Num 4, pp 802-809, issn 0008-543X, 8 p.Article